Monday, May 14, 2007

Mylan Buys Generic Drug Unit

Shares of Mylan Laboratories Inc. (MYL) fell $2.70 to close at $19.70 after the company bought Germany drugmaker Merck KGaA's generic drug business to enter a competitive industry.

0 Comments:

Post a Comment

<< Home